scispace - formally typeset
J

Jennifer Nichols

Researcher at University of Cambridge

Publications -  149
Citations -  35300

Jennifer Nichols is an academic researcher from University of Cambridge. The author has contributed to research in topics: Embryonic stem cell & Cellular differentiation. The author has an hindex of 61, co-authored 137 publications receiving 31645 citations. Previous affiliations of Jennifer Nichols include University of Oxford & University of Edinburgh.

Papers
More filters
Journal ArticleDOI

Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4

TL;DR: It is reported that the activity of Oct4 is essential for the identity of the pluripotential founder cell population in the mammalian embryo and also determines paracrine growth factor signaling from stem cells to the trophectoderm.
Journal ArticleDOI

Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells

TL;DR: These findings establish a central role for Nanog in the transcription factor hierarchy that defines ES cell identity and confirm that Cytokine dependence, multilineage differentiation, and embryo colonization capacity are fully restored upon transgene excision.
Journal ArticleDOI

The ground state of embryonic stem cell self-renewal

TL;DR: It is shown that extrinsic stimuli are dispensable for the derivation, propagation and pluripotency of ES cells and reveal that ES cells have an innate programme for self-replication that does not require extrinsics instruction.
Journal ArticleDOI

BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3

TL;DR: It is reported that bone morphogenetic proteins (BMPs) act in combination with LIF to sustain self-renewal and preserve multilineage differentiation, chimera colonization, and germline transmission properties.
Journal ArticleDOI

Naive and primed pluripotent states.

TL;DR: It is proposed that two phases of pluripotency can be defined: naive and primed, and this distinction extends to pluripotent stem cells derived from embryos or by molecular reprogramming ex vivo.